CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50

Background: Chemotherapy resistance is a major problem in breast cancer treatment and a leading cause of mortality in breast cancer patients. Biomarkers for chemotherapy resistance is under investigation. Methods: Paclitaxel resistant cells were established and subjected to RNA sequencing. Analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Yayun, Xue, Jingyan, Huang, Sheng, Xiu, Bingqiu, Su, Yonghui, Wang, Wei, Guo, Rong, Wang, Lei, Li, Lun, Shao, Zhiming, Jin, Wei, Wu, Zhaohui, Wu, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815964/
https://www.ncbi.nlm.nih.gov/pubmed/31660072
http://dx.doi.org/10.7150/thno.36338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815964/
https://www.ncbi.nlm.nih.gov/pubmed/31660072
http://dx.doi.org/10.7150/thno.36338

Ejemplares similares